A. Taylor

发表

The Source of Fecal Gallium—Clinical Implications: Concise Communication

N. Chafetz, A. Taylor, J. Hollenbeck, 1978 .

Detection of porencephaly by cerbral dynamic scanning

N. Alazraki, J. Slivka, N. Chafetz, 1978, European Journal of Nuclear Medicine.

Comparison of Tc‐99m MAG3 and Tc‐99m DTPA Scintigraphy in Neonates

A. Taylor, S. Clark, T. Ball, 1994, Clinical nuclear medicine.

Comparison of Tc-99m MAG3 and Tc-99m DTPA in Renal Transplant Patients with Impaired Renal Function

J. Ziffer, D. Eshima, A. Taylor, 1990, Clinical nuclear medicine.

Increasing the Dose of Furosemide in Patients With Azotemia and Suspected Obstruction

A. Hunsche, Andrew Taylor, H. Press, 2004, Clinical nuclear medicine.

Transureteroureterostomy Obstruction Mimicking Acute Tubular Necrosis

R. Halkar, F. Esteves, A. Taylor, 2002, Clinical nuclear medicine.

Tc-99m Mercaptoacetyltriglycine Clearance: Comparison of Camera-Assisted Methods

R. Chisin, M. Bocher, M. Klein, 2001, Clinical nuclear medicine.

Comparison of 131I-Tetracycline and 67Ga-Citrate as Abscess Localizing Agents

D. Chauncey, A. Taylor, L. Hagan Philip, 1977, Nuklearmedizin.

Comparison of camera-based 99mTc-MAG3 and 24-hour creatinine clearances for evaluation of kidney function.

M. Issa, R. Halkar, S. Grant, 2006, AJR. American journal of roentgenology.

99mTc-MAG3, a new renal imaging agent: Preliminary results in patients

D. Eshima, N. Alazraki, A. Taylor, 2004, European Journal of Nuclear Medicine.

Variation in Gated Blood-pool Image Quality Using In Vivo, Modified In Vivo, and In Vitro Red Blood Cell Labeling Techniques

P. Christian, J. Ruel, Lisa K. Armstrong, 1986 .

Comparison of a new Tc-99m renal function agent, Tc-99m mercaptoacetyltriglycine, with I-131 OIH

D. Eshima, D. Johnson, A. Fritzberg, 1985 .

A Clinician's Guide to Nuclear Medicine

D. Schuster, N. Alazraki, A. Taylor, 2006 .